Citadel Advisors’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6499 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6535 |
|
|
2024
Q4 | – | Sell |
-95,456
| Closed | -$1.23M | – | 6451 |
|
|
2024
Q3 | $1.23M | Hold |
95,456
| – | – | ﹤0.01% | 2925 |
|
|
2024
Q2 | $1.32M | Buy |
95,456
+8,674
| +10% | +$120K | ﹤0.01% | 2796 |
|
|
2024
Q1 | $27M | Buy |
86,782
+29,557
| +52% | +$9.19M | 0.01% | 753 |
|
|
2023
Q4 | $15M | Buy |
57,225
+254
| +0.4% | +$66.5K | ﹤0.01% | 1001 |
|
|
2023
Q3 | $11.1M | Sell |
56,971
-13
| -0% | -$2.54K | ﹤0.01% | 1101 |
|
|
2023
Q2 | $11.7M | Buy |
56,984
+56,825
| +35,739% | +$11.7M | ﹤0.01% | 1109 |
|
|
2023
Q1 | $16.4K | Sell |
159
-347
| -69% | -$35.8K | ﹤0.01% | 5428 |
|
|
2022
Q4 | $79.4K | Sell |
506
-237
| -32% | -$37.2K | ﹤0.01% | 5116 |
|
|
2022
Q3 | $186K | Buy |
+743
| New | +$186K | ﹤0.01% | 4887 |
|
|
2022
Q1 | – | Sell |
-265
| Closed | -$58K | – | 6794 |
|
|
2021
Q4 | $58K | Buy |
+265
| New | +$58K | ﹤0.01% | 6120 |
|
|
2021
Q3 | – | Sell |
-388
| Closed | -$156K | – | 6808 |
|
|
2021
Q2 | $156K | Buy |
+388
| New | +$156K | ﹤0.01% | 5733 |
|
|
2020
Q3 | – | Sell |
-5,116
| Closed | -$2.9M | – | 5020 |
|
|
2020
Q2 | $2.9M | Buy |
+5,116
| New | +$2.9M | ﹤0.01% | 1921 |
|